Azetidines and cyclobutanes as histamine H3 receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 8, 2014
Grant Date -
May 5, 2011
app pub date -
May 5, 2009
filing date -
May 8, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. These compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully